|
Market Closed -
Nasdaq
01:00:00 14/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.525 USD | -2.68% |
|
-20.92% | +26.86% |
| 11-06 | B. Riley Adjusts Price Target on Novavax to $16 From $18, Keeps Buy Rating | MT |
| 11-06 | Health Care Outperforms Broader Market on AI Rotation - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.41B | - | ||||
| 66.33B | |||||
| 60.62B | |||||
| 55.5B | |||||
| 47.58B | |||||
| 43.69B |
- Stock Market
- Stocks
- NVAX Stock
- Charts Novavax, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
